One-year mortality, stroke, and myocardial infarction rates remain high in the elderly despite beta-blockade plus angiotensin-converting-enzyme inhibition, angiotensin receptor blockade, or both: The VALIANT Trial

Mcmurray, J. (2003) One-year mortality, stroke, and myocardial infarction rates remain high in the elderly despite beta-blockade plus angiotensin-converting-enzyme inhibition, angiotensin receptor blockade, or both: The VALIANT Trial. Circulation, 108(17 Sup), IV-695.

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:McMurray, Professor John
Authors: Mcmurray, J.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
College of Medical Veterinary and Life Sciences
Journal Name:Circulation

University Staff: Request a correction | Enlighten Editors: Update this record